{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:24:37Z","timestamp":1791206677077,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A2C2010964"],"award-info":[{"award-number":["2020R1A2C2010964"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Foundation of Korea,South Korea","award":["2021R1A5A8029876"],"award-info":[{"award-number":["2021R1A5A8029876"]}]},{"name":"National Research Foundation of Korea,South Korea","award":["2020R1I1A1A01073155"],"award-info":[{"award-number":["2020R1I1A1A01073155"]}]},{"name":"National Research Foundation of Korea,South Korea","award":["2014R1A2A2A04006291"],"award-info":[{"award-number":["2014R1A2A2A04006291"]}]},{"name":"SKKU-KSH Future Convergence Research Program"},{"name":"Gachon University Research Fund","award":["GCU-2019-0323"],"award-info":[{"award-number":["GCU-2019-0323"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A simple predictive biomarker for fatty liver disease is required for individuals with insulin resistance. Here, we developed a supervised machine learning-based classifier for fatty liver disease using fecal 16S rDNA sequencing data. Based on the Kangbuk Samsung Hospital cohort (n\u2009=\u2009777), we generated a random forest classifier to predict fatty liver diseases in individuals with or without insulin resistance (n\u2009=\u2009166 and n\u2009=\u2009611, respectively). The model performance was evaluated based on metrics, including accuracy, area under receiver operating curve (AUROC), kappa, and F1-score. The developed classifier for fatty liver diseases performed better in individuals with insulin resistance (AUROC\u2009=\u20090.77). We further optimized the classifiers using genetic algorithm. The improved classifier for insulin resistance, consisting of ten microbial genera, presented an advanced classification (AUROC\u2009=\u20090.93), whereas the improved classifier for insulin-sensitive individuals failed to distinguish participants with fatty liver diseases from the healthy. The classifier for individuals with insulin resistance was comparable or superior to previous methods predicting fatty liver diseases (accuracy\u2009=\u20090.83, kappa\u2009=\u20090.50, F1-score\u2009=\u20090.89), such as the fatty liver index. We identified the ten genera as a core set from the human gut microbiome, which could be a diagnostic biomarker of fatty liver diseases for insulin resistant individuals. Collectively, these findings indicate that the machine learning classifier for fatty liver diseases in the presence of insulin resistance is comparable or superior to commonly used methods.<\/jats:p>","DOI":"10.1038\/s41598-022-26102-4","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:02:42Z","timestamp":1671285762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Machine learning-derived gut microbiome signature predicts fatty liver disease in the presence of insulin resistance"],"prefix":"10.1038","volume":"12","author":[{"given":"Baeki E.","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyekyung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunju","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Gyu","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Min","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosep","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung\u2010Lae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han\u2010Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Auwerx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungyoon","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongryeol","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"key":"26102_CR1","first-page":"167","volume":"11","author":"F Nassir","year":"2015","unstructured":"Nassir, F., Rector, R. S., Hammoud, G. M. & Ibdah, J. A. Pathogenesis and prevention of hepatic steatosis. Gastroenterol. Hepatol. 11, 167\u2013175 (2015).","journal-title":"Gastroenterol. Hepatol."},{"key":"26102_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"26102_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi, Z. M. et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J. Hepatol. 71, 793\u2013801 (2019).","journal-title":"J. Hepatol."},{"key":"26102_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/jhep.2002.30692","volume":"35","author":"S Chitturi","year":"2002","unstructured":"Chitturi, S. et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35, 373\u2013379. https:\/\/doi.org\/10.1053\/jhep.2002.30692 (2002).","journal-title":"Hepatology"},{"key":"26102_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/hep.26672","volume":"59","author":"AL Birkenfeld","year":"2014","unstructured":"Birkenfeld, A. L. & Shulman, G. I. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59, 713\u2013723. https:\/\/doi.org\/10.1002\/hep.26672 (2014).","journal-title":"Hepatology"},{"key":"26102_CR6","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne, C. D. & Targher, G. NAFLD: A multisystem disease. J. Hepatol. 62, S47-64. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012 (2015).","journal-title":"J. Hepatol."},{"key":"26102_CR7","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1097\/01.TP.0000140499.23683.0D","volume":"78","author":"M Iwasaki","year":"2004","unstructured":"Iwasaki, M. et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 78, 1501\u20131505 (2004).","journal-title":"Transplantation"},{"key":"26102_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.dld.2006.03.021","volume":"38","author":"B Palmentieri","year":"2006","unstructured":"Palmentieri, B. et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig. Liver Dis. 38, 485\u2013489 (2006).","journal-title":"Dig. Liver Dis."},{"key":"26102_CR9","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3389\/fmicb.2018.01835","volume":"9","author":"ZY Kho","year":"2018","unstructured":"Kho, Z. Y. & Lal, S. K. The human gut microbiome - a potential controller of wellness and disease. Front. Microbiol. 9, 1835. https:\/\/doi.org\/10.3389\/fmicb.2018.01835 (2018).","journal-title":"Front. Microbiol."},{"key":"26102_CR10","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027\u20131031 (2006).","journal-title":"Nature"},{"key":"26102_CR11","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/nu5030829","volume":"5","author":"AM Caricilli","year":"2013","unstructured":"Caricilli, A. M. & Saad, M. J. The role of gut microbiota on insulin resistance. Nutrients 5, 829\u2013851 (2013).","journal-title":"Nutrients"},{"key":"26102_CR12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cell.2018.09.055","volume":"175","author":"A Koh","year":"2018","unstructured":"Koh, A. et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell 175, 947-961.e917 (2018).","journal-title":"Cell"},{"key":"26102_CR13","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cmet.2020.06.005","volume":"32","author":"TG Oh","year":"2020","unstructured":"Oh, T. G. et al. A universal gut-microbiome-derived signature predicts cirrhosis. Cell Metab. 32, 878-888.e876 (2020).","journal-title":"Cell Metab."},{"key":"26102_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"G Lee","year":"2020","unstructured":"Lee, G. et al. Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD. Nat. Commun. 11, 1\u201313 (2020).","journal-title":"Nat. Commun."},{"key":"26102_CR15","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","volume":"25","author":"R Loomba","year":"2017","unstructured":"Loomba, R. et al. Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab. 25, 1054-1062.e1055 (2017).","journal-title":"Cell Metab."},{"key":"26102_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-16-S18-S1","author":"L Vandewater","year":"2015","unstructured":"Vandewater, L., Brusic, V., Wilson, W., Macaulay, L. & Zhang, P. An adaptive genetic algorithm for selection of blood-based biomarkers for prediction of Alzheimer\u2019s disease progression. BMC Bioinform. https:\/\/doi.org\/10.1186\/1471-2105-16-S18-S1 (2015).","journal-title":"BMC Bioinform."},{"key":"26102_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/hep.30170","volume":"69","author":"Y Chang","year":"2019","unstructured":"Chang, Y. et al. Nonheavy drinking and worsening of noninvasive fibrosis markers in nonalcoholic fatty liver disease: A cohort study. Hepatology 69, 64\u201375 (2019).","journal-title":"Hepatology"},{"key":"26102_CR18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1590-8658(02)80111-6","volume":"34","author":"U Mathiesen","year":"2002","unstructured":"Mathiesen, U. et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild\/moderate abnormalities of liver transaminases. Dig. Liver Dis. 34, 516\u2013522 (2002).","journal-title":"Dig. Liver Dis."},{"key":"26102_CR19","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/oby.22536","volume":"27","author":"YC Hwang","year":"2019","unstructured":"Hwang, Y. C., Ahn, H. Y. & Park, C. Y. Association between nonalcoholic fatty liver disease and future deterioration of metabolic health: A cohort study. Obesity 27, 1360\u20131366 (2019).","journal-title":"Obesity"},{"key":"26102_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jhep.2013.03.035","volume":"59","author":"C-W Kim","year":"2013","unstructured":"Kim, C.-W. et al. Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. J. Hepatol. 59, 351\u2013357 (2013).","journal-title":"J. Hepatol."},{"key":"26102_CR21","first-page":"1191","volume":"115","author":"DA Shephard","year":"1976","unstructured":"Shephard, D. A. The 1975 declaration of Helsinki and consent. Can. Med. Assoc. J. 115, 1191\u20131192 (1976).","journal-title":"Can. Med. Assoc. J."},{"key":"26102_CR22","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1128\/AEM.01043-13","volume":"79","author":"JJ Kozich","year":"2013","unstructured":"Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K. & Schloss, P. D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 79, 5112\u20135120 (2013).","journal-title":"Appl. Environ. Microbiol."},{"key":"26102_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"26102_CR24","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"26102_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn, M. Building predictive models in R using the caret package. J. Stat. Softw. 28, 1\u201326 (2008).","journal-title":"J. Stat. Softw."},{"key":"26102_CR26","first-page":"283","volume-title":"Seminars in Nuclear Medicine","author":"CE Metz","year":"1978","unstructured":"Metz, C. E. Seminars in Nuclear Medicine 283\u2013298 (Elsevier, 1978)."},{"key":"26102_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-019-6413-7","volume":"21","author":"D Chicco","year":"2020","unstructured":"Chicco, D. & Jurman, G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genomics 21, 1\u201313 (2020).","journal-title":"BMC Genomics"},{"key":"26102_CR28","doi-asserted-by":"publisher","first-page":"78368","DOI":"10.1109\/ACCESS.2021.3084050","volume":"9","author":"D Chicco","year":"2021","unstructured":"Chicco, D., Warrens, M. J. & Jurman, G. The Matthews correlation coefficient (MCC) is more informative than Cohen\u2019s Kappa and Brier score in binary classification assessment. IEEE Access 9, 78368\u201378381 (2021).","journal-title":"IEEE Access"},{"key":"26102_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley, J. A. & McNeil, B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29\u201336 (1982).","journal-title":"Radiology"},{"key":"26102_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0022-5193(05)80252-8","volume":"147","author":"BH Sumida","year":"1990","unstructured":"Sumida, B. H., Houston, A. I., McNamara, J. M. & Hamilton, W. D. Genetic algorithms and evolution. J. Theor. Biol. 147, 59\u201384 (1990).","journal-title":"J. Theor. Biol."},{"key":"26102_CR31","doi-asserted-by":"publisher","first-page":"8091","DOI":"10.1007\/s11042-020-10139-6","volume":"80","author":"S Katoch","year":"2021","unstructured":"Katoch, S., Chauhan, S. S. & Kumar, V. A review on genetic algorithm: Past, present, and future. Multimed. Tools Appl. 80, 8091\u20138126 (2021).","journal-title":"Multimed. Tools Appl."},{"key":"26102_CR32","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/bioinformatics\/btl074","volume":"22","author":"V Trevino","year":"2006","unstructured":"Trevino, V. & Falciani, F. GALGO: An R package for multivariate variable selection using genetic algorithms. Bioinformatics 22, 1154\u20131156 (2006).","journal-title":"Bioinformatics"},{"key":"26102_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s12859-019-3001-4","volume":"20","author":"P Zhang","year":"2019","unstructured":"Zhang, P. et al. Selection of microbial biomarkers with genetic algorithm and principal component analysis. BMC Bioinform. 20, 413. https:\/\/doi.org\/10.1186\/s12859-019-3001-4 (2019).","journal-title":"BMC Bioinform."},{"key":"26102_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni, G. et al. The fatty liver index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 1\u20137 (2006).","journal-title":"BMC Gastroenterol."},{"key":"26102_CR35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","volume":"137","author":"A Kotronen","year":"2009","unstructured":"Kotronen, A. et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137, 865\u2013872 (2009).","journal-title":"Gastroenterology"},{"key":"26102_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee, J. H. et al. Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease. Dig. Liver Dis. 42, 503\u2013508 (2010).","journal-title":"Dig. Liver Dis."},{"key":"26102_CR37","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cgh.2016.03.034","volume":"14","author":"MT Long","year":"2016","unstructured":"Long, M. T. et al. Development and validation of the Framingham steatosis index to identify persons with hepatic steatosis. Clin. Gastroenterol. Hepatol. 14, 1172-1180.e1172 (2016).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"26102_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-09455-9","volume":"10","author":"C Caussy","year":"2019","unstructured":"Caussy, C. et al. A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. Nat. Commun. 10, 1\u20139 (2019).","journal-title":"Nat. Commun."},{"key":"26102_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fmicb.2016.00459","volume":"7","author":"J Jovel","year":"2016","unstructured":"Jovel, J. et al. Characterization of the gut microbiome using 16S or shotgun metagenomics. Front. Microbiol. 7, 459 (2016).","journal-title":"Front. Microbiol."},{"key":"26102_CR40","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2014.09.053","volume":"159","author":"JK Goodrich","year":"2014","unstructured":"Goodrich, J. K. et al. Human genetics shape the gut microbiome. Cell 159, 789\u2013799 (2014).","journal-title":"Cell"},{"key":"26102_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13721-1","volume":"10","author":"D Vojinovic","year":"2019","unstructured":"Vojinovic, D. et al. Relationship between gut microbiota and circulating metabolites in population-based cohorts. Nat. Commun. 10, 1\u20137 (2019).","journal-title":"Nat. Commun."},{"key":"26102_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/19490976.2019.1681861","volume":"11","author":"S Astbury","year":"2020","unstructured":"Astbury, S. et al. Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis. Gut Microbes 11, 569\u2013580 (2020).","journal-title":"Gut Microbes"},{"key":"26102_CR43","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.aohep.2018.10.003","volume":"18","author":"F Pi\u00f1ero","year":"2019","unstructured":"Pi\u00f1ero, F. et al. A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma. Ann. Hepatol. 18, 480\u2013487 (2019).","journal-title":"Ann. Hepatol."},{"key":"26102_CR44","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","volume":"65","author":"M Llopis","year":"2016","unstructured":"Llopis, M. et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut 65, 830\u2013839 (2016).","journal-title":"Gut"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26102-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26102-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26102-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:03:34Z","timestamp":1671285814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26102-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["26102"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-26102-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,17]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests, except for S.M.J. and Y.J., who are employed by HEM Pharma Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21842"}}